D K Giger

626 total citations
10 papers, 504 citations indexed

About

D K Giger is a scholar working on Infectious Diseases, Pharmacology and Molecular Medicine. According to data from OpenAlex, D K Giger has authored 10 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 3 papers in Pharmacology and 3 papers in Molecular Medicine. Recurrent topics in D K Giger's work include Antifungal resistance and susceptibility (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Antibiotic Resistance in Bacteria (3 papers). D K Giger is often cited by papers focused on Antifungal resistance and susceptibility (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Antibiotic Resistance in Bacteria (3 papers). D K Giger collaborates with scholars based in United States. D K Giger's co-authors include Alberto M. Marchevsky, Edward J. Bottone, Stephen A. Geller, Judith E. Domer, Robert G. Penn, Laurel C. Preheim, Christine C. Sanders, Kevin L. Garvin, D. Robinson and Stanley J. Radio and has published in prestigious journals such as Journal of Bone and Joint Surgery, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

D K Giger

9 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D K Giger United States	8	213	160	130	90	79	10	504
J Texier-Maugein France	13	149 0.7×	214 1.3×	90 0.7×	102 1.1×	77 1.0×	29	427
S Ånséhn Sweden	14	177 0.8×	210 1.3×	107 0.8×	73 0.8×	103 1.3×	28	688
K Watanabe Japan	14	137 0.6×	142 0.9×	77 0.6×	58 0.6×	57 0.7×	35	509
K T Luh Taiwan	14	254 1.2×	251 1.6×	100 0.8×	58 0.6×	16 0.2×	40	531
Jean-Philippe Émond France	12	88 0.4×	92 0.6×	103 0.8×	82 0.9×	34 0.4×	25	503
C. Watanakunakorn United States	11	227 1.1×	159 1.0×	65 0.5×	112 1.2×	57 0.7×	17	515
Chin-Fu Lin Taiwan	15	215 1.0×	292 1.8×	60 0.5×	159 1.8×	37 0.5×	28	611
Hsiang-Kuang Tseng Taiwan	13	269 1.3×	287 1.8×	91 0.7×	84 0.9×	30 0.4×	31	599
Canan Külah Türkiye	16	185 0.9×	174 1.1×	37 0.3×	220 2.4×	84 1.1×	37	582
Cinzia Calà Italy	12	120 0.6×	84 0.5×	116 0.9×	174 1.9×	38 0.5×	29	504

Countries citing papers authored by D K Giger

Since Specialization

Citations

This map shows the geographic impact of D K Giger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D K Giger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D K Giger more than expected).

Fields of papers citing papers by D K Giger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D K Giger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D K Giger. The network helps show where D K Giger may publish in the future.

Co-authorship network of co-authors of D K Giger

This figure shows the co-authorship network connecting the top 25 collaborators of D K Giger. A scholar is included among the top collaborators of D K Giger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D K Giger. D K Giger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Giger, D K, et al.. (2025). Subacute cutaneous lupus erythematosus-like drug eruption after durvalumab treatment for squamous cell carcinoma. Dermatology Online Journal. 31(5).

Garvin, Kevin L., et al.. (1994). Polylactide/polyglycolide antibiotic implants in the treatment of osteomyelitis. A canine model.. Journal of Bone and Joint Surgery. 76(10). 1500–1506. 134 indexed citations

Giger, D K, et al.. (1993). Failure of the Vitek AutoMicrobic System to Detect Beta-Lactam Resistance inAeromonasSpecies. American Journal of Clinical Pathology. 100(3). 308–310. 6 indexed citations

Thompson, Jon S., et al.. (1988). Morphologic and nutritional responses to intestinal patching following intestinal resection.. PubMed. 103(1). 79–86. 18 indexed citations

Penn, Robert G., Laurel C. Preheim, Christine C. Sanders, & D K Giger. (1983). Comparison of moxalactam and gentamicin in the treatment of complicated urinary tract infections. Antimicrobial Agents and Chemotherapy. 24(4). 494–499. 13 indexed citations

Penn, Robert G., D K Giger, Floyd C. Knoop, & Laurel C. Preheim. (1982). Plesiomonas shigelloides overgrowth in the small intestine. Journal of Clinical Microbiology. 15(5). 869–872. 19 indexed citations

Preheim, Laurel C., Robert G. Penn, Christine C. Sanders, Richard V. Goering, & D K Giger. (1982). Emergence of resistance to beta-lactam and aminoglycoside antibiotics during moxalactam therapy of Pseudomonas aeruginosa infections. Antimicrobial Agents and Chemotherapy. 22(6). 1037–1041. 92 indexed citations

Marchevsky, Alberto M., Edward J. Bottone, Stephen A. Geller, & D K Giger. (1980). The changing spectrum of disease, etiology, and diagnosis of mucormycosis. Human Pathology. 11(5). 457–464. 123 indexed citations

Giger, D K, et al.. (1978). Experimental Murine Candidiasis: Pathological and Immune Responses in T-Lymphocyte-Depleted Mice. Infection and Immunity. 21(3). 729–737. 62 indexed citations

10.

Giger, D K, et al.. (1978). Experimental murine candidiasis: pathological and immune responses to cutaneous inoculation with Candida albicans. Infection and Immunity. 19(2). 499–509. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact